Back to Awarded Treatment Trials


Awarded Trial: 03T-337

Grant ID

03T-337

Illness

Schizophrenia

Primary Drug/Intervention

Suberoylanilide Hydroxamic Acid

Primary Dosage

N/A

Secondary Drug Intervention

N/A

Secondary Dosage

N/A

Other Drug/Intervention

N/A

Other Dosage

N/A

Status

Terminated

Investigator

Potkin

Sample Size

70

Duration of Study Period for Each Subject

4-6 weeks

Outcome Measurements

PANSS, Calgary Depression Scale, ESRS, Barnes Akathisia Scale

Results

Grant terminated in November 2004 due to poor brain availability of the drug.

Publication

N/A

Link

N/A

PI Name

Steven Potkin

Degree

MD

Center

Department of Psychiatry and Human Behavior

Institution

University of California

Address

University of California, Room 161

City or Town

Irvine

State or Province

CA

Zip or Postal Code

92697

Country

USA

Email Address

sgpotkin@uci.edu